P

Inventor

GAUTHIER LAURENT

FR60 patents
⚠️ This page may combine multiple inventors who share the name “GAUTHIER LAURENT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INNATE PHARMA

31 patents
US9764038B2Sep 19, 2017

Enzymatic conjugation of antibodies

INNATE PHARMA38 citations95
US10434180B2Oct 8, 2019

Enzymatic conjugation of polypeptides

INNATE PHARMA20 citations92
US9427478B2Aug 30, 2016

Enzymatic conjugation of polypeptides

INNATE PHARMA30 citations92
US10113003B2Oct 30, 2018

Multispecific NK engager proteins

INNATE PHARMA15 citations91
US9717803B2Aug 1, 2017

Enzymatic conjugation of polypeptides

INNATE PHARMA29 citations91
US10577419B2Mar 3, 2020

KIR3DL2 binding agents

INNATE PHARMA15 citations90
US11267897B2Mar 8, 2022

Multispecific NK engager protein

INNATE PHARMA8 citations84
US10280222B2May 7, 2019

Humanized antibodies with increased stability

INNATE PHARMA8 citations84
US10675359B2Jun 9, 2020

Enzymatic conjugation of antibodies

INNATE PHARMA11 citations83
US10246510B2Apr 2, 2019

KIR3DL2 binding agents

INNATE PHARMA9 citations83
US11001629B2May 11, 2021

Variable regions for NKp46 binding proteins

INNATE PHARMA7 citations82
US10519234B2Dec 31, 2019

NKp46 binding proteins

INNATE PHARMA6 citations82
US9828427B2Nov 28, 2017

Anti-KIR3D antibodies

INNATE PHARMA9 citations80
US11958907B2Apr 16, 2024

CD73 blockade

INNATE PHARMA4 citations73
US11891444B2Feb 6, 2024

Variable regions for NKp46 binding proteins

INNATE PHARMA3 citations73
US11208480B2Dec 28, 2021

Multispecific antigen binding proteins

INNATE PHARMA3 citations73
US11066470B2Jul 20, 2021

Humanized antibodies with increased stability

INNATE PHARMA3 citations73
US10766966B2Sep 8, 2020

CD73 blockade

INNATE PHARMA5 citations72
US11130817B2Sep 28, 2021

CD73 blocking agents

INNATE PHARMA3 citations71
US10132799B2Nov 20, 2018

Screening of conjugated antibodies

INNATE PHARMA3 citations71
US11377503B2Jul 5, 2022

Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptide

INNATE PHARMA3 citations70
US11858990B2Jan 2, 2024

KIR3DL2 binding agents

INNATE PHARMA2 citations69
US11692039B2Jul 4, 2023

Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD123

INNATE PHARMA2 citations67
US12365731B2Jul 22, 2025

NKp46 binding agents

INNATE PHARMA0 citations62
US12227569B2Feb 18, 2025

Humanized antibodies with increased stability

INNATE PHARMA0 citations62
US11377492B2Jul 5, 2022

NKp46 binding agents

INNATE PHARMA1 citations62
US12528876B2Jan 20, 2026

CD73 blocking antibodies

INNATE PHARMA0 citations61
US12252543B2Mar 18, 2025

Multispecific NK engager protein

INNATE PHARMA0 citations61
US11845795B2Dec 19, 2023

NKp46 binding proteins

INNATE PHARMA1 citations61
US11623954B2Apr 11, 2023

Siglec-9-neutralizing antibodies

INNATE PHARMA1 citations60
US12202907B2Jan 21, 2025

Nucleic acids encoding and methods of producing proteins comprising antibody chains

INNATE PHARMA0 citations59

GAUTHIER LAURENT

8 patents

UNIV MONTREAL

2 patents

MORETTA ALESSANDRO

1 patent

SOMFY SAS

1 patent

NOVO NORDISK AS —NOVO ALLE

1 patent

PADKJAER SOREN BERG

1 patent

SIMU

1 patent

ANFOSSI NICOLAS

1 patent

INNATE PHARMA SA

1 patent

AGRONOMIQUE INST NAT RECH

1 patent

FREESCALE SEMICONDUCTOR INC

1 patent

Showing the top 50 of 60 patents by PatentIndex Score.